CHICAGO, April 18, 2024 /PRNewswire/ -- Data infrastructure and analytics company Kalderos, Inc., today announced that on Tuesday, April 16, it asked the Eighth Circuit for leave to file an amicus brief in support of Pharmaceutical Research and Manufacturers of America's (PhRMA's) petition for rehearing in the Arkansas contract pharmacy litigation.
Key Points:
- CHICAGO, April 18, 2024 /PRNewswire/ -- Data infrastructure and analytics company Kalderos, Inc., today announced that on Tuesday, April 16, it asked the Eighth Circuit for leave to file an amicus brief in support of Pharmaceutical Research and Manufacturers of America's (PhRMA's) petition for rehearing in the Arkansas contract pharmacy litigation.
- Kalderos asked the U.S. Court of Appeals for the Eighth Circuit for permission to file an amicus brief in support of PhRMA's petition for rehearing en banc of the court's decision holding that Arkansas Act 1103 is not preempted by federal law.
- Arkansas Act 1103 prohibits drug manufacturers from denying access to federal 340B drug pricing by Arkansas-based contract pharmacies receiving drugs purchased pursuant to an arrangement with a covered entity under the 340B Program.
- Kalderos submitted this brief in support of the petition for rehearing because the decision upsets the existing regulatory structure of the 340B Program adopted by Congress.
CHICAGO, March 26, 2024 /PRNewswire/ -- Data infrastructure and analytics company Kalderos, creator of the world's first Drug Discount Management platform, today announced the hiring of veteran legal professional Rusty Hensley as general counsel.
Key Points:
- CHICAGO, March 26, 2024 /PRNewswire/ -- Data infrastructure and analytics company Kalderos, creator of the world's first Drug Discount Management platform, today announced the hiring of veteran legal professional Rusty Hensley as general counsel.
- Hensley is the first general counsel in the history of Kalderos, founded in 2016.
- In his 20 years of experience as a general counsel, Hensley has been a core member of leadership teams that drove profitability for their companies.
- Prior to that, Hensley was general counsel for five years at Vispero, an assistive technology for the visually impaired.
Retrieved on:
Tuesday, February 27, 2024
CHICAGO, Feb. 27, 2024 /PRNewswire/ -- Data infrastructure and analytics company Kalderos, creator of the world's first Drug Discount Management platform, today announced the addition of two experienced and highly respected industry veterans to its board of directors.
Key Points:
- CHICAGO, Feb. 27, 2024 /PRNewswire/ -- Data infrastructure and analytics company Kalderos, creator of the world's first Drug Discount Management platform, today announced the addition of two experienced and highly respected industry veterans to its board of directors.
- The establishment of a national clearinghouse aligns closely with Kalderos' goal to bring a claims-based 340B price effectuation model to market.
- The addition of the new board members adds experience and technical acumen to addressing these industry issues.
- "Their insights and guidance will be invaluable during this transitional time for the Medicaid Drug Rebate Program and the 340B Drug Pricing Program."
Retrieved on:
Wednesday, January 17, 2024
Patient,
Head,
Medicaid,
OM1,
Health care,
Labcorp,
Health,
Marketing,
Inflation,
Growth,
Pharmaceutical industry CHICAGO, Jan. 17, 2024 /PRNewswire/ -- Data infrastructure and analytics company Kalderos, creator of the world's first Drug Discount Management platform, today announced the hiring of two senior executives to drive its operational excellence, product innovation, and stakeholder satisfaction.
Key Points:
- Pharmaceutical companies spend more than $250 billion annually in discounts and rebates, and 2022's Inflation Reduction Act mandates even more pricing concessions.
- Kalderos has built a platform that uses transparent data to bring drug discount stakeholders together, enabling discounts and rebates to be paid more accurately and efficiently.
- "We are fortunate to have two healthcare technology and pharmaceutical industry veterans, each with decades of respective experience, join our executive leadership team as we continue to rapidly grow across our customer base and platform capabilities," said Kalderos CEO Angie Franks.
- In addition to several other healthcare technology leadership positions, his pharmaceutical industry experience includes surpassing numerous revenue goals and developing successful teams as director of sales at Covance (now LabCorp) and district sales manager at Scherling-Plough.
Retrieved on:
Wednesday, November 8, 2023
Inflation Reduction Act of 2022,
Software as a service,
Education,
HIPAA,
Yale school,
Yale School of Management,
Think Small,
MBA,
Engineering,
Jan Vansina,
History,
IIT Madras,
Growth,
Risk,
Business,
Machine learning,
Risk assessment,
University,
AI,
Inflation,
Management,
Automation,
Accounting,
COTA,
Mechanical engineering CHICAGO, Nov. 8, 2023 /PRNewswire/ -- Data infrastructure and analytics company Kalderos, creator of the world's first Drug Discount Management platform, today announced the hiring of two senior executives with impressive track records of innovation and business growth.
Key Points:
- Jim Sparks joins Kalderos as chief financial officer, while Sudhakar Velamoor has been named chief technology officer.
- Both are new executive roles at Kalderos, as the company positions itself as the market leader in drug discount management for pharmaceuticals and other stakeholders.
- With yet more cost and complexity ahead, drug discount management represents a vast market in need of tech-enabled infrastructure.
- The expanded role speaks to Kalderos' commitment to maintaining best-in-class standards for information security as the company scales.
Retrieved on:
Wednesday, September 20, 2023
Health,
Manufacturing,
Health care,
Allina Health,
Electronic health record,
The CEO Show with Robert Reiss,
Government,
Patient,
EHR,
Bain Capital Ventures,
Growth,
Pharmaceutical industry,
Nursing CHICAGO, Sept. 20, 2023 /PRNewswire/ -- Data infrastructure and analytics company Kalderos, creator of the world's first Drug Discount Management platform, today announced the appointment of longtime healthcare executive Angie Franks as chief executive officer.
Key Points:
- For more than 30 years, Franks has demonstrated the ability to successfully lead organizational change and complex growth strategy in the healthcare sector.
- Prior to joining Kalderos, Franks served for more than six years as CEO of ABOUT Healthcare, a leading provider of solutions for orchestrating patient access for complex acute and post-acute referrals.
- She also was CEO of Electronic Health Records (EHR) vendor Healthland from 2010 to 2013, serving rural and critical access hospitals.
- "I am in awe of Angie's deep healthcare experience, and her track record of success aligning teams to execute aggressive growth plans and strategy," said Kalderos founder and former CEO Jeremy Docken.
Retrieved on:
Thursday, September 14, 2023
CHICAGO, Sept. 14, 2023 /PRNewswire/ -- Data infrastructure and analytics company Kalderos, creator of the world's first Drug Discount Management platform, today unveiled a transformative refresh to its Commercial Discount Monitoring solution that helps drug manufacturers better use data to inform their commercial contract strategies with pharmacy benefit managers (PBMs).
Key Points:
- The Commercial Discount Monitoring solution leverages cloud-based data and analytics with integrated detection of 340B duplicates and other contractually ineligible rebates across commercial discount programs, providing customers with actionable insights on the terms and performance of their contracts.
- Tapping more than 20 data sets across government and commercial drug programs, the enhanced Commercial Discount Monitoring solution includes a proprietary 340B validation set that is six times more extensive than conventional methods.
- The enhanced Commercial Discount Monitoring solution features new proprietary validations that bring in more datasets and catch more potential duplicate discounts than ever.
- Building on this expertise, Kalderos is now solidifying its offering in the commercial space with the enhanced Commercial Discount Monitoring solution.
CHICAGO, June 13, 2023 /PRNewswire/ -- Data infrastructure and analytics company Kalderos, creator of the world's first Drug Discount Management platform, released its 2023 annual report today. The report, titled "Mission Critical: Bringing drug discount stakeholders together so patients win," outlines Kalderos' vision for a new paradigm of cooperation among drug discount program stakeholders in which everyone benefits — particularly patients.
Key Points:
- The report, titled " Mission Critical: Bringing drug discount stakeholders together so patients wi n ," outlines Kalderos' vision for a new paradigm of cooperation among drug discount program stakeholders in which everyone benefits — particularly patients.
- As the Medicaid Drug Rebate Program (MDRP), 340B Drug Pricing Program and other similar programs expand, so do the volume and cost of duplicate discounts and other inaccurate drug discount claims.
- Between 2016 and Q1 2023, Kalderos' MDRP Discount Monitoring solution identified nearly $1 billion in inaccurate discount requests.
- Drug discount programs are critical for the support they provide safety-net healthcare providers and their patients, many of whom live in vulnerable communities.
SCOTTSDALE, Ariz., April 4, 2023 /PRNewswire/ -- Amendola, a nationally recognized, award-winning healthcare technology and life sciences public relations and marketing firm, announced today that Kalderos, creator of the world's first Drug Discount Management platform, has chosen the firm to amplify client successes, thought leadership, and industry best practices.
Key Points:
- Amendola is implementing a comprehensive PR plan to demonstrate Kalderos' industry-leading technology and services, new offerings, accomplishments, customer wins, and industry partnerships.
- "Drug discount programs are complex and multilayered, creating challenges for manufacturers seeking to reduce revenue leakage and bolster program integrity," said Brent Dover, CEO of Kalderos.
- Welcoming Kalderos to the Amendola agency roster, Amendola CEO Jodi Amendola states, "It is an incredible honor to work with the Kalderos team to educate the industry on how Kalderos' Drug Discount Management solutions enable manufacturers to verify duplicate discounts, mitigate revenue leakage, and provide true data transparency.
- Kalderos recently introduced Kalderos for Manufacturers , a new portal designed exclusively for drug manufacturers to ensure a simplified, more efficient way to process drug discount claims.
Retrieved on:
Monday, February 27, 2023
CHICAGO, Feb. 27, 2023 /PRNewswire/ -- Data infrastructure and analytics company Kalderos, creator of the world's first Drug Discount Management platform, today introduced a new portal designed exclusively for drug manufacturers to ensure a simplified, more efficient way to process drug discount claims.
Key Points:
- CHICAGO, Feb. 27, 2023 /PRNewswire/ -- Data infrastructure and analytics company Kalderos, creator of the world's first Drug Discount Management platform, today introduced a new portal designed exclusively for drug manufacturers to ensure a simplified, more efficient way to process drug discount claims.
- The new purpose-built product suite, which replaces the Verify tool, will allow manufacturers to better leverage Kalderos' one-of-a-kind multi-sided platform that has been proven to improve efficiency across drug discount programs.
- Earlier this year, Kalderos introduced a portal exclusively to serve covered entities participating in drug discount programs.
- We believe our latest approach to tailoring each product suite to specific program stakeholders will ensure a better experience for all who participate and benefit from these drug discount programs."
